Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Jinxin Fertility GroupHKSE:01951 -2.26%81 EV-to-FCF is 21.95 as of Aug. 10, 2026, which is 8% below its 10-year median of 23.81. GuruFocus rates HKSE:01951 with a GF Score™ of 81/100 and a GF Value™ of HK$3.74 (Possible Value Trap). The stock has 8 warning signs investors should review. Among 405 Healthcare Providers & Services companies, Jinxin Fertility Group ranks worse than 58.52% on this metric.
EV-to-FCF is calculated as enterprise value divided by its free cash flow. As of today, Jinxin Fertility Group's Enterprise Value is HK$7,832 Mil.
Jinxin Fertility Group's Free Cash Flow for the trailing twelve months (TTM) ended in Dec. 2025 was HK$357 Mil. Therefore, Jinxin Fertility Group's EV-to-FCF for today is 21.95.
The historical rank and industry rank for Jinxin Fertility Group's EV-to-FCF or its related term are showing as below:
HKSE:01951'
s EV-to-FCF Range Over the Past 10 Years
Min: -2928.59 Med: 23.81 Max: 151.33
Current: 21.95
During the past 10 years, the highest EV-to-FCF of Jinxin Fertility Group was 151.33. The lowest was -2928.59. And the median was 23.81.
HKSE:01951's EV-to-FCF is ranked worse than 58.52% of 405
companies
in the Healthcare Providers & Services industry
Industry Median: 18.84
vs HKSE:01951: 21.95
EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
Jinxin Fertility Group (HKSE:01951) EV-to-FCF Explanation
EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
Jinxin Fertility Group's PE Ratio (TTM) for today is calculated as:
Jinxin Fertility Group's share price for today is HK$2.16.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Jinxin Fertility Group's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2025 was HK$-0.393.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Free Cash Flow is an important financial metric because it represents the actual amount of cash at a company's disposal. Companies with a low EV-to-FCF ratio, combined with a strong balance sheet are generally considered as undervalued.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Care Facilities subindustry, Jinxin Fertility Group's EV-to-FCF, along with its competitors' market caps and EV-to-FCF data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Jinxin Fertility Group EV-to-FCF vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Jinxin Fertility Group's EV-to-FCF distribution charts can be found below:
* The bar in red indicates where Jinxin Fertility Group's EV-to-FCF falls into.
Jinxin Fertility Group's current Enterprise Value is HK$7,832 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Jinxin Fertility Group's Free Cash Flow for the trailing twelve months (TTM) ended in Dec. 2025 was HK$357 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Jinxin Fertility Group (HKSE:01951) has a EV-to-FCF of 21.95 as of Aug. 10, 2026. EV to FCF ratio is the company's enterprise value divided by free cash flow. View historical data on Jinxin Fertility Group and its competitors. This is near median its historical median of 23.81. According to the industry distribution chart, Jinxin Fertility Group ranks #237 out of 405 companies in the Healthcare Providers & Services industry, placing it in the top 58.5%.
Is Jinxin Fertility Group's EV-to-FCF too high?
Jinxin Fertility Group's current EV-to-FCF of 21.95 is near median its 10-year median of 23.81. The Healthcare Providers & Services industry median EV-to-FCF is 18.84. Jinxin Fertility Group's value of 21.95 is 16.5% above this industry median. Based on the distribution chart, Jinxin Fertility Group ranks #237 out of 405 companies in the Healthcare Providers & Services industry, which is below the industry midpoint. Overall, Jinxin Fertility Group has a GF Score™ of 81/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Jinxin Fertility Group's EV-to-FCF compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, Jinxin Fertility Group ranks #237 out of 405 companies for EV-to-FCF. This places Jinxin Fertility Group in the lower half of its industry. The industry median EV-to-FCF is 18.84. Jinxin Fertility Group's value of 21.95 is 16.5% above this benchmark. While the company's 10-year median is 23.81 vs. the industry median of 18.84, Jinxin Fertility Group has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-FCF for a Healthcare Providers & Services company?
The median EV-to-FCF among Healthcare Providers & Services companies is 18.84, based on 405 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-FCF significantly above this median, while those in the bottom quartile fall well below. However, EV-to-FCF should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Jinxin Fertility Group's current EV-to-FCF of 21.95 is 16.5% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-FCF mean?
A high EV-to-FCF can signal that a stock is expensive relative to its fundamentals. EV to FCF ratio is the company's enterprise value divided by free cash flow. View historical data on Jinxin Fertility Group and its competitors. For the Healthcare Providers & Services industry, the median EV-to-FCF is 18.84 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Jinxin Fertility Group's current EV-to-FCF is 21.95, which is near median its own 10-year median of 23.81. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Jinxin Fertility Group stock overvalued right now?
Based on GuruFocus' analysis, Jinxin Fertility Group (HKSE:01951) is currently considered Possible Value Trap. The stock's GF Value™ is HK$3.74, compared to a current price of HK$2.16 — trading 42.2% below its estimated fair value. The current EV-to-FCF is 21.95, which is near median its 10-year median of 23.81 and 16.5% above the Healthcare Providers & Services industry median of 18.84. Jinxin Fertility Group's overall GF Score™ is 81/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-FCF calculated?
EV-to-FCF is calculated from a company's financial statements. For Jinxin Fertility Group (HKSE:01951), the current EV-to-FCF is 21.95 as of Aug. 10, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Jinxin Fertility Group (HKSE:01951) Overvalued in 2026?
Based on GuruFocus' analysis, Jinxin Fertility Group stock appears to be undervalued.
The current stock price of HK$2.16 is trading 42.2% below its estimated GF Value™ of HK$3.74.
GuruFocus considers Jinxin Fertility Group to be Possible Value Trap.
Key valuation signals for HKSE:01951:
EV-to-FCF: 21.95 (near median its 10-year median of 23.81)
GF Value™: HK$3.74 vs. price of HK$2.16 (42.2% below fair value)
Industry Position: 16.5% above the Healthcare Providers & Services median (#237 of 405)
No single metric tells the full story. See the HKSE:01951 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Jinxin Fertility Group Ltd is an investment holding company. Along with its subsidiaries, it is engaged in providing IVF services in both China and the United States. The firm, through its subsidiary, is engaged in Assisted reproductive services, management services, ambulatory surgery centre facilities services, obstetrics, gynecology & pediatrics medical services, sales of medical consumables and equipment. and ancillary medical services. Geographically, the company generates a majority of its revenue from Greater China, with a small portion of revenue generated from Overseas Business.
81GF Score
Get the complete analysis for HKSE:01951
EV-to-FCF is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
HKSE:01951 has been successfully added to your 
